Pediatric Psychotropic Medication Adherence
Vanya Hamrin, RN, MSN, APRN-PMHCS, BC – Associate Professor, Vanderbilt University School of Nursing Biography
Disclosures: Discussion of off-label uses (using products for a purpose other than that for which it was approved by the Food and Drug Administration, or FDA) will occur during this presentation. The speaker has no conflicts of interest to disclose. The activity planners have no conflicts of interest to disclose.
Session Length: 90 minutes
Upon completion of this presentation, the participant will be able to:
1. Understand the factors that determine families’ decisions to initiate, sustain or discontinue use of psychotropic medications for children and adolescents.
2. Explore the costs and benefits of psychotropic medications according to children and parents.
3. Utilize strategies that will promote mental health treatment of children and adolescents with psychiatric disorders.
4. Learn medication assessment questions that may aid with medication compliance.
Continuing Nursing Education
1.5 contact hours. * In order to receive contact hours, you must: Listen to the entire session, complete an evaluation, and earn a passing score on the post test before the expiration date. You will have 5 tries to earn a score of 80% or better on the post test. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. We cannot award credit unless all steps are completed.
The content of this CNE activity pertains to pharmacology. Because states' requirements may vary, contact your Board of Nursing for more information.
The American Psychiatric Nurses Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
APNA 9th Annual Clinical Psychopharmacology Institute
Sunday, June 19, 2011
1:30pm – 3:00pm
Release Date: August 24, 2011
Contact hours for this session expire: December 1, 2014